Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD, however, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established.
Abstract
Aim
A systematic review was conducted to clarify the association between long-term prenatal systemic glucocorticoid use of at least 7 days and offspring neurodevelopmental and neuropsychiatric outcomes.
Methods
PubMed, Embase, Web of Science, the Cumulative Index to Nursing and Allied Health Literature, Cochrane Library and PsycINFO were searched from inception to March 8, 2026. We identified four observational studies that evaluated prenatal systemic glucocorticoid exposure and offspring neurodevelopmental outcomes, including autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD) and intellectual disability (ID). Study quality was assessed, and a narrative synthesis was performed.
Results
Three nationwide cohorts (covering more than 1.2 million pregnancies) reported significantly elevated risks of ASD and ADHD following prenatal glucocorticoid exposure (adjusted risk ratio 1.3-1.5). The association with ID was inconsistent and non-significant (risk ratio 1.1-1.4). A single-centre study of 74 subjects did not find any significant cognitive differences.
Conclusion
Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD. However, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established. Glucocorticoid use should focus on the lowest dose and shortest duration, with clear counselling. Further research is required.
TRIAL REGISTRATION
International Prospective Register of Systematic Reviews: CRD420261327850.
Background The long-term effects of antidepressant use in pregnancy on child neurodevelopment are unclear; meanwhile antidepressant use in pregnancy is increasing. We aimed to clarify associations between prenatal maternal depression and/or antidepressant exposure and neurodevelopmental outcomes in school-age children....
Although maternal hyperglycemia may influence fetal neurodevelopment through inflammatory and metabolic mechanisms, the observational nature and limited number of included studies preclude causal inference, and these findings should be interpreted with caution.
Marianna Zanette Molha, Ana Julia de Magalhães Pina, Beatriz Yukie Filosi et al.· Revista Brasileira de Psiqui...· 0 citations
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system with a complex etiology involving genetic and environmental factors. Maternal diabetes during pregnancy has been hypothesized to influence offspring MS risk through intrauterine metabolic programming, yet the evidence remains incon...
Mehdi Mohammadifar, Mahyar Ghajarzdaeh, M. Ghajarzadeh· Neurological Sciences· 0 citations
A large population-based study in Asia found no increased risk of NDDs in offspring following paternal exposure to valproate or other ASMs, which may contribute to ongoing debates about the management of valproate in men of reproductive age.
Y. A. Feng, Mei-Chen Lin, Ching-Hsuan Tseng et al.· Neurology· 0 citations
BACKGROUND
Maternal coronavirus disease 2019 (COVID-19) during pregnancy was common during the pandemic. However, its potential risks for clinically diagnosed neurodevelopmental disorders in offspring, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and intellectual disability...
Y. Okubo, Kazuhiro Uda· The Pediatric Infectious Dis...· 0 citations